|
|
||||||||
Neuroscience Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), AIST Central 6, 1-1-1 Higashi, Tsukuba 305-8566, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
However, knock-out mice lacking the BMP antagonists, Cerberus, follistatin, noggin and/or chordin, still develop a nervous system (Vonica & Brivanlou 2006). BMP inhibition is only required as a late step during neural induction in the chicken (Linker & Stern 2004). In Xenopus, BMP antagonists cannot induce neural markers when FGF signaling is blocked (Launay et al. 1996; Sasai et al. 1996). Recently, BMPs and the ligands in the BMP pathways are shown to signal in dissociated cells at the same level as in intact animal cap cells (Kuroda et al. 2005).
To further explore the molecular mechanisms of epidermal differentiation, we have developed a functional screening system for isolating cDNAs that encode proteins with epidermal-inducing activity in the early vertebrate embryo. None of the known epidermal factors have been identified using expression cloning to isolate proteins with epidermalizing activity. Among the transforming growth factor-β (TGF-β) family, BMPs were originally identified as molecules that can induce ectopic bone and cartilage formation in rodents (Wozney et al. 1988). Wilson & Hemmati-Brivanlou (1995) showed that BMP-4 inhibits neuralization of dissociated animal caps, promoting the formation of epidermis. BMP-2 and BMP-7 were identified as a homolog of BMP-4 (Suzuki et al. 1997); DGF6 was identified by a differential screening using TGF-β probes (Chang & Hemmati-Brivanlou 1999). Many genes involved in epidermal induction through the BMP-Smad signaling pathway were characterized: BMPs and their downstreams including receptors and Smads (Muñoz-Sanjuán & Brivanlou 2002; De Robertis & Kuroda 2004).
In contrast to profound insight into the BMPs and the BMP-involved signaling pathways, little is known about endogenous factor(s) that have epidermal-inducing and/or neutralization-inhibiting activities in the development of embryos. Therefore, we first established culture conditions and an assay system to evaluate the epidermal-inducing activity. A cDNA library was prepared from Xenopus-developing embryos, transcribed in vitro and the RNAs were subjected to the functional assays. Thus, we identified Xenopus zygote arrest 2 (Zar2), which is homologous to Zar1, as an epidermalization-promoting factor during early embryogenesis. We demonstrated that Xzar2 can promote epidermal and inhibit neural differentiation in dissociated animal cap cells and embryos of Xenopus. Our results suggest that Xzar2 is involved in epidermal fate determination mainly through signaling pathways distinct from that of BMP-Smad during early embryogenesis.
| Results |
|---|
|
|
|---|
Animal cap cells dissected and dissociated from blastulae at stage 8: 50% of the cells develop into neural tissue extending nerve fibers (Godsave & Slack 1989). We modified the procedures to improve the neural fate ratio, so that we could use it for expression cloning of epidermal inducers. The experimental scheme is shown in Fig. 1. Briefly, cells were taken from the inner surface of the animal cap of stage 8 midblastulae and incubated in CMFM for 4 h. Then the cells were dispensed into about 20 cells per microculture well. Most cells were divided and aggregated to make spheroids. Then nerve fibers extended out in 92.6% of the microculture wells (Table 1 upper section, arrowheads in Fig. 2A,a). These results suggested that cells from animal caps of blastula embryos were directed to develop into neural tissue under our standard culture condition.
|
|
|
To examine whether cDNAs coding for epidermal inducers, if present, could change the neural fate of the cells to epidermis into our microculture system, we used the BMP-4 cDNA: mRNA was synthesized, injected into Xenopus oocytes, and the culture medium of the oocytes was subjected to the assay (Table 1 lower section). In the case of treatment with the supernatant of BMP-4 mRNA-injected oocytes, cells with cilia were present in 87.3% of the microculture wells. Following treatment of the cells with the supernatant of H2O-injected oocytes, however, 2.5% of the microcultures showed ciliate development and mostly extended nerve fibers. These results suggested the feasibility of the assay to identify novel epidermal inducers on the basis of morphological changes.
Neural cell and epidermis have been identified using antibodies AP-20 and E3, respectively; AP-20 is highly reactive with the microtubule-associated protein 2 (MAP2), which is localized in dendrites and somas, and E3 selectively recognizes differentiated epidermal cells (Mitani & Okamoto 1989). A neural antigen was detected in the cells with nerve fibers (Fig. 2B, a and b) and an epidermal antigen was detected on the surface of the cells with cilia (Fig. 2B, c and d). To further assess whether each marker gene was expressed, we performed RT-PCR after the microculture with oocyte medium, in which BMP-4 mRNA- or H2O-injected oocytes were maintained. RNA was extracted from cells cultured under our conditions and assayed for the expression of cell-type-specific molecular markers by RT-PCR. Intact animal caps expressed the epidermal keratin gene and did not express the general neural marker, neural cell adhesion molecule (NCAM, Fig. 2C, lane 3). In the absence of epidermal inducer, NCAM was turned on under the microculture condition (Fig. 2C, lane 2). The epidermal keratin gene was switched off, indicating that these cells had neuralized. Transcripts of Xenopus Brachyury (Xbra), which is a marker of both notochord and ventral/posterior mesoderm at this stage were detected in extracts of whole embryo (Fig. 2C, lane 4). When supernatant collected from BMP-4 mRNA-injected oocytes was included during dissociation in CMFM, the epidermal keratin was expressed and the neural gene was repressed (Fig. 2C, lane 1), indicating their differentiation into epidermis. Mesoderm was not induced under this condition. The recognition and expression of neural and epidermal markers indicate that proteins secreted by the oocytes had altered the developmental fate of the dissociated animal cap cells, from nerve tissue to epidermis under our culture conditions.
Expression cloning of Xzar2 assayed by its epidermaling effects
We used the assay in a screen for secreted proteins capable of causing epidermal induction in the dissociated animal cap cells of blastula embryos. cDNAs were prepared from the blastula embryo poly(A)+ RNA and the sized cDNA (0.7–5.0 kbp) was ligated into the plasmid vector, pSD64TRER. The cDNA library was divided into 20 pools (~5000 clones per pool), from which mRNAs were synthesized in vitro. Each mRNA pool was assessed by two criteria: epidermal-inducing activity and the presence of a known soluble epidermal inducer, such as BMPs and GDF6. mRNAs generated from each pool were injected into oocytes and the incubation medium of the oocytes was subjected to the dissociated microculture assay. The presence of the clones encoding BMP-2, -4, -7, and GDF6 was analyzed by RT-PCR (Fig. 3). About 50 000 clones have been screened (50% of the library). Two pools, no. 3 and no. 8, met the criteria out of the seven active pools with epidermal-inducing activity (Fig. 3). Pool no. 8 was selected for subsequent sib selections until a single active clone. We isolated several active clones. One of the active clones showed high similarity to Xenopus zygote arrest 1 (zar1; Wu et al. 2003b); the similarity was 50.8% (Fig. 4). Therefore, we refer to it as Xenopus zygote arrest 2 (Xzar2). The full-length Xzar2 cDNA encodes a protein of 303 amino acids. Comparison of amino acid sequences of Xzar2 and zar1 from six species revealed conserved regions (Fig. 4). As is evident, the C-termini of the proteins were highly conserved. Similar to zar1 (Wu et al. 2003a,b), an atypical PHD motif was also identified in the C-terminal of Xzar2 protein (asterisks in Fig. 4).
|
|
To explore the temporal pattern of Xzar2 expression, RT-PCR analysis was performed on embryos harvested during embryonic development (Fig. 5A). Xzar2 RNA was expressed maternally and maintained its level until stage 10. The expression decreased significantly around stage 12 (Fig. 5A). The spatial distribution of Xzar2 transcripts was investigated by whole-mount in situ hybridization (Fig. 5B). At the blastula and gastrula stages, Xzar2 was expressed uniformly in the ectodermal and the mesodermal regions. After neurula and tailbud stages, no localized Xzar2 transcripts were observed (data not shown). No signal was detected with a sense control probe at any stage (data not shown). Next, we transfected HEK-293 cells with pEGFP-N1-Xzar2 and examined its intracellular localization. Xzar2 was localized mainly in the nucleus (Fig. 5C).
|
Xzar2 cDNA was identified by its epidermal promoting activity after morphologic observation. To confirm the Xzar2 activity, dissociated cells were treated with the culture medium of synthetic Xzar2 mRNA-injected oocytes for 4 h. Cells were dispensed at the mid-gastrula stages and then cultured for 3 days in NAM/2. RNA was extracted and assayed for the expression of cell-type-specific molecular markers by RT-PCR (Fig. 6A). Cells from control embryos dissociated in this manner showed a strong expression of NCAM, and no expression of epidermal keratin (Fig. 6A, lane 3). Cells dissociated in the presence of BMP-4 expressed epidermal keratin (Fig. 6A, lane2). Like cells treated with BMP-4, cells treated with the culture medium of Xzar2 mRNA-injected oocytes did not express NCAM, but expressed epidermal keratin (Fig. 6A, lane 1). The mesodermal marker, Xbra, was not induced in these cells. These results suggested that Xzar2 has a role in early epidermal gene expression and an inhibition of neural gene expression.
|
Over-expression of Xzar2 in anterior brain region results in neural inhibition
Next, we performed an over-expression of Xzar2 to examine the effect of Xzar2 in neurogenesis. The Xzar2 mRNA was injected into a single animal-dorsal blastomere of an eight-cell stage embryo (Fig. 6D). Injection of Xzar2 mRNA caused a failure of head formation (Fig. 6E,b), especially normal eye formation in the injected embryos, while no defects were observed in embryos injected with control mRNA (Fig. 6E,a) at stage 32. Histological examination confirmed that lens vesicle was defective and eye vesicle was decreased in the Xzar2 mRNA-injected embryos (Fig. 6F,b). These defects were strongly observed in the injected side in particular (Fig. 6F,b). The other side of the injection was also had a minor defect: the size of the eyes were decreased (compare left sides of a with b in Fig. 6F). Furthermore, in situ hybridization revealed a reduction in the expression of neural markers; Xrx1A (Fig. 6G,b) and Sox2 (Fig. 6G,d) in the embryos derived from Xzar2 mRNA-injected blastomeres. The expressions were not affected in the control embryos (Fig. 6G,a and c). These results suggest that over-expression of Xzar2 may suppress normal development of anterior.
Xzar2 promotes epidermal differentiation through signaling pathway(s) different from the BMP pathway
BMPs transduce their signals via two types of serine/threonine kinase receptors, type I and type II, both of which are required for signal transduction. Inhibitory Smads (I-Smads), consisting of Smad6 and Smad7, can inhibit the BMP signaling pathway (von Bubnoff & Cho 2001). Smad6 has been reported to be associated with BMP type I receptors, thereby preventing receptor-mediated activation of receptor-regulated Smads (R-Smads: Smad1, 2, 3, 5 and 8 in vertebrates). Smad7 can likewise bind stably to type I receptors, thus precluding activation of R-Smads. Smad6 also competes with Smad4 for binding to receptor-activated Smad1.
To examine whether I-Smads could inhibit the epidermal differentiation concerned with Xzar2, we tested the effects of the corresponding transcripts, I-Smads and Xzar2, on the expression of epidermal markers in the animal cap assay. Initially, we injected mRNAs encoding Smad6 (1.2 ng), Smad7 (1.2 ng), Xzar2 (640 pg) and/or BMP4 (640 pg) into two-cell embryos. Animal caps were isolated at stage 8 and expressions of each marker genes were analyzed at stage 26 by RT-PCR. Over-expression of Smad6 and Smad7 induced expression of NCAM in animal caps and did not induce epidermal keratin (Fig. 7A: lanes 1 and 2 compared with 7). Smad6 and 7 inhibited the epidermal induction by BMP-4 (Fig. 7A: lanes 3 and 5). However, the epidermal differentiation by over-expression of Xzar2 was not inhibited by co-injection of Smad6 or 7 (Fig. 7A: lanes 4 and 6).
|
| Discussion |
|---|
|
|
|---|
Using the cloning system we have identified several cDNA, each of which is responsible for the epidermal differentiation of the dissociated animal cap cells. In this study, we have characterized one of the clones, Xzar2, which has sequence similarity to Xenopus zygote arrest 1 (Zar1: Wu et al. 2003b). Zar1 is an ovary-specific maternal factor that plays an essential role during the oocyte-to-embryo transition in mouse (Wu et al. 2003a), but the actual function of the protein is unknown. Our results show for the first time that Xzar2 in a Zar family can be involved in neural development at an early stage of embryogenesis. In Xenopus, Zar1 expression is detected in the mature oocyte through the tailbud-stage of embryogenesis, although the level of expression decreases dramatically during the neurula stage and eventually disappears altogether in tadpole-stage embryos (Wu et al. 2003b). Xzar2 expression is also detected during early zygotic stages (Fig. 5A). Moreover, the expression was detected in the ectodermal and the mesodermal regions (Fig. 5B). The Zar1 from the six species contains a highly conserved atypical PHD motif, which is a conserved C8 pattern (C-X2-C-X13-C-X2-C-X4-C-X1-C-X17-C-X2-C; Wu et al. 2003b). Similar to Zar1, an atypical PHD motif was also identified in the C-terminus of Xzar2 (Fig. 4 [asterisks]). The PHD domain is found in two major classes of proteins: (i) transcriptional activators, repressors, or cofactors (Aasland et al. 1995; Gibbons et al. 1997; Capili et al. 2001) and (ii) subunits of complexes that modulate chromatin (Aapola et al. 2002). Xzar2 is localized in the nucleus of HEK-293 cells (Fig. 5C). Thus, Xzar2 may play a role as a transcriptional regulator of secreted proteins concerned with epidermal differentiation.
The present model for neural induction (the default model) proposes neural fate as the default pathway that ectodermal cells would acquire in the absence of any signal (Chang & Hemmati-Brivanlou 1998). This fate is inhibited in the ectoderm by an active BMP signaling. The organizer secretes BMP antagonists, which block BMP signaling in adjacent cells, allowing them to follow their default neural pathway (Muñoz-Sánjuan & Brivanlou 2002). Dissociated animal cap cells that subsequently re-aggregate develop into neural tissues (Godsave & Slack 1989; Sato & Sargent 1989), and this induction can be blocked by the addition of BMP-4 protein (Wilson & Hemmati-Brivanlou 1995). Misexpression of BMP in the prospective neural plate ventralizes the embryo, as well as suppressing neural markers. In this study, we clearly showed that Xzar2 can promote the epidermal differentiation at the expense of the neural differentiation (Fig. 6A,C). Misexpression of Xzar2 induces anterior defects, such as dysgenesis of an eye (Fig. 6E,F), and suppression of neural markers (Sox2 and Xrx1A; Fig. 6G). These indicate that Xzar2 may play a critical role for epidermal differentiation in ectoderm by inducing the expression of secretory factor(s). However, we cannot rule out the possibility that Xzar2 affects anterior neural development directly or through the other pathway(s) at the moment.
An important question is whether the other family member Zar1 has analogous activity to Zar2. Dissociated animal cap assay shows that the secretory factor(s) activated by Xzar1 has a role in early epidermal gene expression and an inhibition of neural gene expression (Supporting Fig. S1). Because the other Zar family member may compensate for the loss of Xzar2, the injection of Xzar2 MO alone could not inhibit the expression of epidermal keratin (Fig. 6C). Recently, a novel protein, which is structurally related to Zar1, was found in human and cattle, and was named Zar1-like (Sangiorgio et al. 2008). On the basis of our result, it is interesting to suppose that the Zar related genes may be involved in differentiation of vertebrate.
Epidermal differentiation, using the supernatant derived from the Xzar2-mRNA-injected oocytes, suggests that Xzar2 promotes epidermal differentiation via soluble factor(s) that are activated through the epidermal signaling pathway. At present, BMP and the following signaling pathway are well studied for the epidermal induction event. Inhibitory Smads (I-Smads) consist of vertebrate Smad6 and Smad7, which are members of the TGF-β superfamily. I-Smads inhibit BMP signaling by binding with the intracellular domain of activated BMP type I receptors (Miyazono et al. 2005), and by competing with Smad4 for binding to receptor-activated Smad1, thereby preventing formation of an active Smad1-Smad4 complex, and can function as a transcriptional co-repressor to antagonize BMP signaling in the nucleus. Recently, in the chick, misexpression of BMP-4 or BMP-7 in the prospective neural plate did not block neural induction (Streit et al. 1998). In Xenopus, endogenous BMPs continue to signal in dissociated animal cap ectodermal cells, at the same levels as in undissociated cells (Kuroda et al. 2005). These results suggest that BMP inhibition may not be absolutely required for neural induction, and that the other molecules may be implicated in the process. In addition, we have shown that over-expression of Smad6 or Smad7 did not inhibit epidermal differentiation by Xzar2 (Fig. 7A). When tBR was over-expressed, Xzar2 could still induce epidermis in the dissociated animal cap assay (Fig. 7B). Our results indicate that the pathway(s) different from BMP pathway is involved in epidermal differentiation during early embryogenesis.
From our results, Xzar2 may play an important role in the early patterning of Xenopus embryo. Nevertheless, it remains unclear what kind of secretory factor(s) is activated by the injection of Xzar2 mRNA in oocytes. We show that noggin blocks promotion of epidermal differentiation by Xzar2 (Supporting Fig. S2). Furthermore, when the culture medium collected from Xzar2-mRNA injected oocytes was mixed with the noggin-conjugated beads, epidermal differentiation promoted by Xzar2 was abolished by incubation with the medium (data not shown). Our data show that noggin can bind to and inhibit secretory factor(s) that is activated by injection of Xzar2 mRNA in oocytes. Further studies will be required to reveal the target molecule(s) that Xzar2 interacts with and the signaling cascade thereafter through epidermalization.
| Experimental procedures |
|---|
|
|
|---|
Methods for keeping frogs and for obtaining embryos followed those described by Mitani & Okamoto (1989). All experiments were performed in compliance with the guidelines of the National Institute of Advanced Industrial Science and Technology.
Cell culture
Midblastula embryos (stage 8 according to Nieuwkoop & Faber 1967) were dejellied in 2% cysteine hydrochloride (pH 7.8) and kept in a modified Barth solution (MBS) on ice until the subsequent operation. Operations were carried out in NAM/2 (Godsave & Slack 1989) on a 1% agarose cushion. Embryos were manually removed from the vitelline membrane and were cut out discs of tissue from the center of the animal pigmented hemisphere using hair loops. Then the animal caps were placed in a dissociating medium (PhoNaK: Godsave & Slack 1989). Unpigmented inner cells were separated by a gentle stream of medium. Dispersed cells were cultured for 4 h at 22 °C in calcium- and magnesium-free medium (CMFM: 5 mM HEPES substituted for Tris; Wilton & Melton 1994) with or without recombinant human BMP-4 (rhBMP-4, GT) or supernatants of culture medium from H2O- or mRNA-injected oocytes. The incubations were carried out in agarose-coated four-well dishes (Nunc); cells equivalent to two caps were induced in a single well containing 500 µL of solution. Then about 20–30 cells were transferred to a well of Terasaki plate (Nunc) containing 15 µL of NAM/2 and cultured for 68 h at 22 °C. The wells were pretreated with 2 µL of 100 µg/mL laminin (Invitrogen) and 100 µg/mL fibronectin (Invitrogen) in NAM/2 (Godsave et al. 1988). After removing the solution, the wells were allowed to dry and were filled with NAM/2 for culture.
Functional expression in Xenopus oocytes
This was done essentially as previously described (Kimura & Kubo 2003). For mRNA synthesis, plasmid DNAs pSDRER-XBMP4, pSDRER-Xzar2, pSDRER-Smad6, and pSDRER-Smad7, pSP64T-tBR, pSDRER-Xzar1, pSDRER-noggin were linearized with XbaI or BamHI. In the case of mRNA synthesis from the cDNA pools, we used the circular DNAs as templates. Capped synthetic RNAs were generated by in vitro transcription with SP6 RNA polymerase using a MEGAscript transcription kit (Ambion). Injected oocytes were incubated in CMFM for 1 day before collecting the supernatant.
cDNA library construction
Total RNA was isolated from X. laevis embryos at stage 8 by TRIZOL® (Invitrogen) and poly(A)+ RNA was selected by OligotexTM-dT30 (Takara). cDNA library construction was performed as previously described (Inagaki et al. 2004), with slight modifications. First-strand cDNAs were synthesized by ReverTra Ace (Toyobo) and Superscript II (Invitrogen) with NXho(dT)30 primer [5'-AAGCAGTGGTAACAACGCAGAGTCTCGAG (T)30 (GAC) (GTAC)-3']. The second strands were synthesized with DNA polymerase I, RNase H and Escherichia coli DNA ligase (Takara). After both ends of the double-stranded cDNAs were filled with a DNA blunting kit (Takara), EcoRI adapters (Clontech) were added to the cDNAs. The cDNAs were then digested with XhoI and fractionated by agarose gel electrophoresis. The cDNA fragments with length of 0.7–5.0 kbp were cloned into the EcoRI and XhoI sites of pSDRER vector (modified pSD64TR: Zhao et al. 1994) which contained 5' and 3' UTRs of Xenopus β-globin and SP6 promoter. Aliquots from the unamplified library were plated on LB-agar plates containing 50 µg/mL ampicillin. After an overnight incubation at room temperature and 37 °C, the transformants were collected from each plate and pooled (~5000 colonies per plate). The bacteria were stored as a 15% glycerol stock at –80 °C.
Staining of cultured cells
Indirect immunostaining was performed as described elsewhere (Mitani & Okamoto 1991) with the following modifications: cells were fixed with 0.5% paraformaldehyde in NAM/2 for 2 h on ice. After fixation, culture plates were washed by gentle dipping into potassium phosphate-buffered saline (PBS; pH 7.4), and PBS containing 50 mM glycine for 1 h at 4 °C. For indirect immunofluostaining, each culture well received 10 µL of a first layer monoclonal antibody (mAb) containing 1% (for E3, specific for epidermis; Mitani & Okamoto 1989) or 0.2% (for AP-20, specific for dendrites and somas) of NP-40 (Sigma). After incubation for 2 h at room temperature, the plates were washed by gentle dipping into PBS. The washing solution was changed four times each for 20 min. The plates were finally removed from PBS solution and the excess PBS in the plates was aspirated off. Each well then received 10 µL of Alexa Fluor® 488 goat anti-mouse IgG (H + L: Molecular Probes) containing 1% BSA. After a 1-h incubation at room temperature and washing as before, the cells were stained with 5 µg/mL propidium iodide (PI: Dojindo) after treatment with RNase (4 mg/mL). Finally, the cells were observed under a laser scanning confocal microscope (Lsm 410: Zeiss).
Microinjection and RT-PCR
Microinjection of mRNA was performed as previously described (Hongo et al. 1999). mRNAs were injected in 640 pg per blastomere at the two-cell stage, or 320 pg per blastomere at the eight-cell stage, of Xenopus embryos. Cells were collected from two culture plates or six animal cap explants for each experimental point and RNA was extracted by TRIZOL® reagent (Invitrogen) as described above. RT-PCR was carried out as previously described (Hongo et al. 1999). Primers used for RT-PCR were as follows: BMP-2, 5'-CAGAGGAAGGCAAACGCAAG-3' and 5'-AGCCGCCGC TGGCTTGACAA-3'; BMP-4, 5'-GCATGTAAGGATAAGTC GATC-3' and 5'-GATCTCAGACTCAACGGCAC-3'; BMP-7, 5'-ACAGTAAAGAGAAGATTGCC-3' and 5'-CTGCGGAGAT GGATATCTGA-3'; GDF6, 5'-GAATACGGATCTGCTTTGC AGG-3' and 5'-GGACTCAGTTTGAACAGGTGCC-3'; Xzar2, 5'-TACAGACTGTGCGCGCTTCTCCCGC-3' and 5'-TTCCT CTTCATTGGGCTCCTCAGC-3'; EF1
, 5'-CAGATTGGTGC TGGATATGC-3' and 5'-ACTGCCTTGATGACTCCTAG-3'; ODC, 5'-GTCAATGATGGAGTGTATGGATC-3' and 5'-TCC ATTCCGCTCTCCTGAGCAC-3'; Epidermal keratin, 5'-CAC CAGAACACAGAGTAC-3' and 5'-CAACCTTCCCATCAAC CA-3'; NCAM, 5'-CACAGTTCCACCAAATGC-3' and 5'-GGAATCAAGCGGTACAGA-3'; Xbra, 5'-GGATCGTTATC ACCTCTG-3' and 5'-GTGTAGTCTGTAGCAGCA-3'.
Whole-mount in situ hybridization
The technique was performed as previously described (Watanabe et al. 2005). Xzar2 probe was synthesized with SP6 RNA polymerase on KpnI linearized pSPT19-Xzar2 (591 bp 5' region, 1 to 591) template. The markers used in this experiment were Sox2 and Xrx1A.
Transfection
HEK 293 cells (human embryonic kidney cell line) were cultured in Dulbecco's modified Eagle's medium (DMEM, Sigma) supplemented with 10% fetal calf serum and 5 mM penicillin-streptomycin (Gibco). A coding region of Xzar2 plus Kozak sequence was cloned into pEGFP-N1 (Clontech). In preparation for transfection experiments, cells were cultured in 35-mm dishes for 24 h. The next day, the culture medium changed to DMEM without penicillin-streptomycin. Cells were transfected with pEGFP-N1 or pEGFP-N1-Xzar2 using LipofectamineTM 2000 (Invitrogen). After a 3-h incubation, the culture medium changed to DMEM supplemented with 10% fetal calf serum and 5 mM penicillin-streptomycin. Cells were analyzed with the confocal scanning system (Olympus, FluoView FV1000) after 48 h.
Histological examination
Embryos cultured until stage 32 were fixed in Bouin's solution for 1 h. They were dehydrated through ethanol series, embedded in paraffin (Wako) and sectioned at 6–10 µm. The sections were stained in hematoxylin (Lab Vision) and eosin (Chroma-Gesellschaft).
Morpholino oligonucleotide experiments
Antisense morpholinos (Xzar2 MO 5'-ATGGCGGGGTTTGTG TATTCTCCGT-3' and control MO 5'-ATGCCGGCGTTTC TGTATTGTCGGT-3', which contains nucleotide exchange, underline) were directed against sequences the 5' end of the Xzar2 transcript. MOs were dissolved in water and injected into blastomeres at varying concentrations of oligonucleotide. In vitro transcription/translation was performed using the TNT® Coupled Reticulocyte Lysate System (Promega) and [35S] methionine (20 mCi/reaction). In one set of experiments, control or Xzar2 MO was injected into both cells of the two-cell embryo. An Xzar2 cDNA that mutated (underline, 5'-ATGGCTGGATTCGTCTACGCC CCTTAC-3') was used to rescue MO treatment.
| Acknowledgements |
|---|
| Footnotes |
|---|
aPresent address: Graduate School of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8572, Japan
| References |
|---|
|
|
|---|
Aasland, R., Gibson, T.J. & Stewart, A.F. (1995) The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem. Sci. 20, 56–59.[CrossRef][Medline]
Bouwmeester, T., Kim, S., Sasai, Y., Lu, B. & De Robertis, E.M. (1996) Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer. Nature 382, 595–601.[CrossRef][Medline]
von Bubnoff, A. & Cho, K.W.Y. (2001) Intracellular BMP signaling regulation in vertebrates: pathway or Network? Dev. Biol. 239, 1–14.[CrossRef][Medline]
Capili, A.D., Schultz, D.C., Rauscher III, F.J. & Borden, K.L. (2001) Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domains. EMBO J. 20, 165–177.[CrossRef][Medline]
Chang, C. & Hemmati-Brivanlou, A. (1998) Xenopus GDF6, a new antagonist of noggin and a partner of BMPs. J. Neurobiol. 36, 128–151.[CrossRef][Medline]
Chang, C. & Hemmati-Brivanlou, A. (1999) Xenopus GDF6, a new antagonist of noggin and a partner of BMPs. Development 126, 3347–3357.[Abstract]
De Robertis, E.M. & Kuroda, H. (2004) Dorsal-ventral patterning and neural induction in Xenopus embryos. Annu. Rev. Cell Biol. 20, 285–308.[CrossRef]
Gibbons, R.J., Bachoo, S., Picketts, D.J., et al. (1997) Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nat. Genet. 17, 146–148.[CrossRef][Medline]
Godsave, S.F., Isaacs, H.V. & Slack, J.M.W. (1988) Mesoderm inducing factors: a small class of molecules. Development 102, 555–566.[Abstract]
Godsave, S.F. & Slack, J.M.W. (1989) Clonal analysis of mesoderm induction in Xenopus laevis. Dev. Biol. 134, 486–490.[CrossRef][Medline]
Hemmati-Brivanlou, A., Kelly, O.G. & Melton, D.A. (1994) Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neuralizing activity. Cell 77, 283–295.[CrossRef][Medline]
Hongo, I., Kengaku, M. & Okamoto, H. (1999) FGF signaling and the anterior neural induction in Xenopus. Dev. Biol. 15, 561–581.
Inagaki, H., Akagi, M., Imai, H.T., Taylor, R.W. & Kubo, T. (2004) Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia. Arch. Biochem. Biophys. 15, 170–178.
Kimura, T. & Kubo, T. (2003) Cloning and functional characterization of squid voltage-dependent Ca2+ channel beta subunits: involvement of N-terminal sequences in differential modulation of the current. Neurosci. Res. 46, 105–117.[CrossRef][Medline]
Kuroda, H., Fuentealba, L., Ikeda, A., Reversade, B. & De Robertis, E.M. (2005) Default neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation. Genes Dev. 19, 1022–1027.
Launay, C., Fromentoux, V., Shi, D.L. & Boucaut, J.C. (1996) A truncated FGF receptor blocks neural induction by endogenous Xenopus inducers. Development 122, 869–880.[Abstract]
Linker, C. & Stern, C.D. (2004) Neural induction requires BMP inhibition only as a late step, and involves signals other than FGF and Wnt antagonists. Development 131, 5671–5681.
Mitani, S. & Okamoto, H. (1989) Embryonic development of Xenopus studied in a cell culture system with tissue-specific monoclonal antibodies. Development 105, 53–59.[Abstract]
Mitani, S. & Okamoto, H. (1991) Inductive differentiation of two neural lineages reconstituted in a microculture system from Xenopus early gastrula cells. Development 112, 21–31.[Abstract]
Miyazono, K., Maeda, S. & Imamura, T. (2005) BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16, 251–263.[CrossRef][Medline]
Muñoz-Sanjuán, I. & Brivanlou, A.H. (2002) Neural induction, the default model and embryonic stem cells. Nat. Rev. Neurosci. 3, 271–280.[CrossRef][Medline]
Nieuwkoop, P.D. & Faber, J. (1967) Normal Table of Xenopus Laevis (Daudin). North-Holland publishing Company, Amsterdam.
Sangiorgio, L., Strumbo, B., Brevin, T.A.L., Severino, R. & Simonic, T. (2008) A putative protein structurally related to zygote arrest 1 (Zar1), Zar-like, is encoded by a novel conserved in the vertebrate lineage. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 150, 233–239.[CrossRef][Medline]
Sasai, Y., Lu, B., Piccolo, S. & De Robertis, E.M. (1996) Endoderm induction by the organizer-secreted factors chordin and noggin in Xenopus animal caps. EMBO J. 15, 4547–4555.[Medline]
Sasai, Y., Lu, B., Steinbeisser, H., Geissert, D., Gont, L.K. & De Robertis, E.M. (1994) Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell 79, 779–790.[CrossRef][Medline]
Sasai, N., Takura, R., Kamiya, D., Nakagawa, Y. & Sasai, Y. (2008) Ectodermal factor restricts mesoderm differentiation by inhibiting p53. Cell 133, 878–890.[CrossRef][Medline]
Sato, S.M. & Sargent, T.D. (1989) Development of neural inducing capacity in dissociated Xenopus embryos. Dev. Biol. 134, 263–266.[CrossRef][Medline]
Seed, B. (1995) Developments in expression cloning. Curr. Opin. Biotechnol. 6, 567–557.[CrossRef][Medline]
Smith, W.C. & Harland, R.M. (1992) Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70, 829–840.[CrossRef][Medline]
Streit, A., Lee, K.J., Woo, I., Roberts, C., Jessell, T.M. & Stern, C.D. (1998) Chordin regulates primitive streak development and the stability of induced neural cells, but is not sufficient for neural induction in the chick embryo. Development 125, 507–519.[Abstract]
Suzuki, A., Kaneko, E., Ueno, N. & Hemmati-Brivanlou, A. (1997) Regulation of epidermal induction by BMP2 and BMP7 signaling. Dev. Biol. 189, 112–122.[CrossRef][Medline]
Vonica, A. & Brivanlou, A.H. (2006) An obligatory caravanserai stop on the silk road to neural induction: inhibition of BMP/GDF signaling. Semin. Cell Dev. Biol. 17, 117–132.[CrossRef][Medline]
Watanabe, T., Hongo, I., Kidokoro, Y. & Okamoto, H. (2005) Functional role of a novel ternary complex comprising SRF and CREB in expression of Krox-20 in early embryos of Xenopus laevis. Dev. Biol. 277, 508–521.[CrossRef][Medline]
Wilson, P.A. & Hemmati-Brivanlou, A. (1995) Induction of epidermis and inhibition of neural fate by Bmp-4. Nature 376, 331–333.[CrossRef][Medline]
Wilton, P.A. & Melton, D.A. (1994) Mesodermal patterning by an inducer gradient depends on secondary cell-cell communication. Curr. Biol. 4, 676–686.[CrossRef][Medline]
Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M. & Wang, E.A. (1988) Novel regulators of bone formation: molecular clones and activities. Science 242, 1528–1534.
Wu, X., Viveiros, M.M., Eppig, J.J., Bai, Y., Fitzpatrick, S.L. & Matzuk, M.M. (2003a) Zygote arrest 1 (Zar1) is a novel maternal-effect gene critical for the oocyte-to-embryo transition. Nat. Genet. 33, 187–191.[CrossRef][Medline]
Wu, X., Wang, P., Brown, C.A., Zilinski, C.A. & Matzuk, M.M. (2003b) Zygote arrest 1 (Zar1) is an evolutionarily conserved gene expressed in vertebrate ovaries. Biol. Reprod. 69, 861–867.
Zhao, B., Rassendren, F., Kaang, B.K., Furukawa, Y., Kubo, T. & Kandel, E.R. (1994) A new class of noninactivating K+ channels from Aplysia capable of contributing to the resting potential and firing patterns of neurons. Neuron 13, 1205–1213.[CrossRef][Medline]
Received: 5 November 2008
Accepted: 16 February 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |